Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma
Clin. transl. oncol. (Print)
; 18(2): 206-211, feb. 2016. ilus, graf
Article
en En
| IBECS
| ID: ibc-148226
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
Purpose. EBER-1 (a non-coding RNA transcribed by EBV) expression was detected in most of Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (NPC) patients. However, the relevance between EBER-1 expression and NPC clinical outcome has not been reported. This study aims to assess the possible correlations of EBER-1 expression and clinical parameters and its potential prognostic predictive ability in NPC patients outcomes. Methods. We examined EBER-1 mRNA expression in 301 NPC and 130 non-NPC tissues using in situ hybridization and did statistics. Results. EBER-1 expression was up-regulated in NPC tissues when compared to non-NPC tissues. A receiver operating characteristic analysis revealed that EBER-1 expression could distinguish non-cancerous patients from NPC patients (p < 0.001, sensitivity: 72.5 %, specificity: 83.5 %, AUC = 0.815). A survival analysis revealed that patients with high levels of EBER-1 expression had a significantly good prognosis (Disease-free survival: p = 0.019, overall survival: p = 0.006). Conclusion. These results indicated that EBER-1 expression is a potential prognosis factor of NPC and highly negative correlated with the progress of NPC (AU)
RESUMEN
No disponible
Buscar en Google
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Fenotipo
/
Carcinoma
/
Neoplasias Nasofaríngeas
/
Apoptosis
/
Infecciones por Virus de Epstein-Barr
/
Ácido Gástrico
/
Consentimiento Informado
Tipo de estudio:
Diagnostic_studies
/
Evaluation_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Año:
2016
Tipo del documento:
Article